Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Apotex agreed to pay $39.1 million and Heritage Pharmaceuticals will pay $10 million to settle claims by Connecticut and other states that accused them of conspiring to artificially inflate prices. Read more: https://t.co/P0ImsTLgPR https://t.co/BoDIY5ZNU8
Nevada's attorney general joined a coalition along with 50 states to announce $49.1 million in settlements. https://t.co/nXZ2i5jy5j
Today, my office entered into two settlements with generic drug manufacturers over claims that these companies conspired to inflate their prices and limit competition, harming Marylanders by their conduct. Pharmaceutical manufacturers must comply with antitrust laws to ensure… https://t.co/MHj1LwVZpN
Blue Cross Blue Shield has agreed to a $2.8 billion settlement to resolve an antitrust case, as announced by Cozen O'Connor. In a separate development, drug manufacturers Apotex and Heritage Pharmaceuticals have agreed to pay a combined total of $49 million to settle price-fixing claims brought by multiple states. Specifically, Apotex will pay $39.1 million while Heritage will contribute $10 million. These settlements address allegations that the companies conspired to inflate drug prices and limit competition, which has adversely affected consumers, particularly in Maryland and Connecticut, among other states.
